<- Go Home
Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
Market Cap
EUR 1.7B
Volume
1.1M
Cash and Equivalents
EUR 231.3M
EBITDA
EUR 15.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 106.5M
Profit Margin
13.70%
52 Week High
EUR 21.69
52 Week Low
EUR 5.06
Dividend
N/A
Price / Book Value
1.71
Price / Earnings
-9.65
Price / Tangible Book Value
2.46
Enterprise Value
EUR 1.8B
Enterprise Value / EBITDA
69.17
Operating Income
-EUR 60.1M
Return on Equity
-16.25%
Return on Assets
-1.77
Cash and Short Term Investments
EUR 303.3M
Debt
EUR 470.1M
Equity
EUR 968.5M
Revenue
EUR 777.1M
Unlevered FCF
-EUR 181.9M
Sector
Life Sciences Tools and Services
Category
N/A